aromatase inhibitors

Preferred Label : aromatase inhibitors;

MeSH definition : Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.;

MeSH synonym : inhibitors, aromatase; Aromatase Inhibitor; Inhibitor, Aromatase;

Wikipedia link : https://en.wikipedia.org/wiki/Aromatase inhibitor;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D047072;

UMLS CUI

C0593802;

ATC code(s)
- Aromatase inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Aromatase inhibitor (disposition) [SNOMED CT concept]
- Aromatase inhibitors [ICD-11 Extension code]
- Product containing aromatase inhibitor (product) [SNOMED CT concept]
- Substance with aromatase inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Aromatase Inhibitor [NCIt concept]
- Aromatase inhibitors [ATC Code]
Indexing information
- 1,4,6-androstatrien-3,17-dione [MeSH Supplementary Concept]
- 1-pentyl-3-(4-aminophenyl)pyrrolidine-2,5-dione [MeSH Supplementary Concept]
- 10-amino-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-fluoroethindrone [MeSH Supplementary Concept]
- 10-hydroperoxy-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-methylthioethyl estra-4,9(11)-diene 3,17-dione [MeSH Supplementary Concept]
- 10-oxirane-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-thiirane-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 14-hydroxyandrost-4-ene-3,6,17-trione [MeSH Supplementary Concept]
- 17 beta-hydroxy-10-methylthioestra-1,4-dien-3-one [MeSH Supplementary Concept]
- 17-bromoacetoxy-4-androsten-3-one [MeSH Supplementary Concept]
- 17-hydroxy-10-mercaptoestr-4-en-3-one [MeSH Supplementary Concept]
- 19,19-difluoroandrost-4-en-17-one [MeSH Supplementary Concept]
- 19-(cyclopropylamino)androst-4-en-3,17-dione [MeSH Supplementary Concept]
- 19-(ethyldithio)androst-4-ene-3,17-dione [MeSH Supplementary Concept]
- 19-amino-4-androstene-3,17-dione [MeSH Supplementary Concept]
- 19-azidoandrost-4-ene-3,17-dione [MeSH Supplementary Concept]
- 19-ethynyl-19-hydroxyandrost-4-en-17-one [MeSH Supplementary Concept]
- 19-hydroxyandrost-5-ene-4,17-dione [MeSH Supplementary Concept]
- 19-mercaptoandrost-4-ene-3,17-dione [MeSH Supplementary Concept]
- 19-thiomethylandrost-4-ene-3,17-dione [MeSH Supplementary Concept]
- 2',4'-dihydroxy-2''-(1-hydroxy-1-methylethyl)dihydrofuro(2,3-h)flavanone [MeSH Supplementary Concept]
- 2,19-(methyleneoxy)androst-4-ene-3,17-dione [MeSH Supplementary Concept]
- 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione [MeSH Supplementary Concept]
- 2-(imidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine [MeSH Supplementary Concept]
- 2-N,N-dimethylamino-4,6-bis(1-H-imidazol-1-yl)-1,3,5-triazine [MeSH Supplementary Concept]
- 3'-demethoxysecoisolariciresinol [MeSH Supplementary Concept]
- 3'-hydroxymethylmethylallyl-2,4,2',4'-tetrahydroxychalcone 11'-O-coumarate [MeSH Supplementary Concept]
- 3-(4'-aminophenyl)-3-ethylpyrollidine-2,5-dione [MeSH Supplementary Concept]
- 3-(4'-aminophenyl)pyrrolidine-2,5-dione [MeSH Supplementary Concept]
- 3-(4-aminophenyl)-3-cyclohexylpiperidine-2,6-dione [MeSH Supplementary Concept]
- 3-(cyclohexylmethyl)-1-(4-aminophenyl)-3-azabicyclo(3.1.0)hexane-2,4-dione [MeSH Supplementary Concept]
- 3-aminophenoxazone [MeSH Supplementary Concept]
- 3-butyl-3-(4-pyridyl)piperidine-2,6-dione [MeSH Supplementary Concept]
- 3-demethoxy-3'-O-demethylmatairesinol [MeSH Supplementary Concept]
- 3-hydroxyandrost-4-ene-6,17-dione [MeSH Supplementary Concept]
- 4,5-epoxyandrosta-3,6,17,19-tetraone [MeSH Supplementary Concept]
- 4,5-epoxyandrostenedione [MeSH Supplementary Concept]
- 4-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)phenyl sulfamate [MeSH Supplementary Concept]
- 4-(2,6-dihydroxybenzoyl)-3-formyl-5-hydroxybenzoic acid [MeSH Supplementary Concept]
- 4-(phenylthio)-4-androstene-3,17,dione [MeSH Supplementary Concept]
- 4-acetoxy-4-androstene-3,17-dione [MeSH Supplementary Concept]
- 4-phenoxy-7-phenylthio-4-androstene-3,17-dione [MeSH Supplementary Concept]
- 4-phenylthio-1,4,6-androstatriene-3,17-dione [MeSH Supplementary Concept]
- 4-phenylthio-1,4-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 4-phenylthioandrosta-4,6-diene-3,17-dione [MeSH Supplementary Concept]
- 4-tert-butylcyclohexyl 4-pyridylacetate [MeSH Supplementary Concept]
- 5,6-epoxyandrosta-7,17,19-trione [MeSH Supplementary Concept]
- 5,7,2',4'-tetrahydroxy-3-geranylflavone [MeSH Supplementary Concept]
- 5alpha-androst-3-en-17-one oxime [MeSH Supplementary Concept]
- 6-ethylandrost-4-ene-3,17-dione [MeSH Supplementary Concept]
- 6-ethylandrosta-1,4,6-triene-3,17-dione [MeSH Supplementary Concept]
- 6-hydroperoxyandrost-4-ene-3,17-dione [MeSH Supplementary Concept]
- 7-((4'-aminophenyl)thio)-1,4-androstadiene-3,17-dione [MeSH Supplementary Concept]
- 7-(3,4-difluorophenoxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one [MeSH Supplementary Concept]
- 7-(4'-amino)phenylthioandrostenedione [MeSH Supplementary Concept]
- 7-benzyl-1,4,6-androstatriene-3,17-dione [MeSH Supplementary Concept]
- 7-phenethyl-1,4,6-androstatriene-3,17-dione [MeSH Supplementary Concept]
- 7-phenyl-1,4,6-androstatriene-3,17-dione [MeSH Supplementary Concept]
- C-octylpyridoglutethimide [MeSH Supplementary Concept]
- CGP 45688 [MeSH Supplementary Concept]
- CGS 14796C [MeSH Supplementary Concept]
- CGS 18320B [MeSH Supplementary Concept]
- FCE 27993 [MeSH Supplementary Concept]
- FR 901537 [MeSH Supplementary Concept]
- LY 183648 [MeSH Supplementary Concept]
- LY 43578 [MeSH Supplementary Concept]
- LY 56110 [MeSH Supplementary Concept]
- MDL 102253 [MeSH Supplementary Concept]
- MEN 11066 [MeSH Supplementary Concept]
- MFT 279 [MeSH Supplementary Concept]
- MR 20492 [MeSH Supplementary Concept]
- MR 20494 [MeSH Supplementary Concept]
- N,N-didesmethyl-4-hydroxytamoxifen [MeSH Supplementary Concept]
- N-(4-hydroxyundecanoyl)anabasine [MeSH Supplementary Concept]
- N-methyl-3-(4'-aminophenyl)-3-ethylpyrrolidine-2,5-dione [MeSH Supplementary Concept]
- N-octanoylnornicotine [MeSH Supplementary Concept]
- N-octylpyridoglutethimide [MeSH Supplementary Concept]
- TZA 2209 [MeSH Supplementary Concept]
- TZA 2237 [MeSH Supplementary Concept]
- YM 511 [MeSH Supplementary Concept]
- YM 553 [MeSH Supplementary Concept]
- androst-4-ene-3,6,17-trione [MeSH Supplementary Concept]
- androst-4-ene-6,17-dione [MeSH Supplementary Concept]
- androst-5-ene-4,17,19-trione [MeSH Supplementary Concept]
- androst-5-ene-4,17-dione [MeSH Supplementary Concept]
- androst-5-ene-7,17-dione [MeSH Supplementary Concept]
- demethylmoracin I [MeSH Supplementary Concept]
- dexaminoglutethimide [MeSH Supplementary Concept]
- ergosterol-5,8-peroxide [MeSH Supplementary Concept]
- finrozole [MeSH Supplementary Concept]
- isogemichalcone C [MeSH Supplementary Concept]
- leflutrozole [MeSH Supplementary Concept]
- minamestane [MeSH Supplementary Concept]
- org 33201 [MeSH Supplementary Concept]
- rogletimide [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- aromatase [MeSH Descriptor]
Record concept(s)
- aromatase inhibitors [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3,4-epoxy-5alpha-androstan-17-one [MeSH Supplementary Concept]
- Anastrozole [MeSH Descriptor]
- Letrozole [MeSH Descriptor]
- aminoglutethimide [MeSH Descriptor]
- exemestane [MeSH Supplementary Concept]
- fadrozole [MeSH Descriptor]
- formestane [MeSH Supplementary Concept]
- intraovarian peptides [MeSH Supplementary Concept]
- plomestane [MeSH Supplementary Concept]
- vorozole [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Aromatase Inhibitor [NCIt concept]
- Aromatase inhibitors [ATC Code]
- Product containing aromatase inhibitor (product) [SNOMED CT concept]
- Substance with aromatase inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients